Cardinal Health, Inc.(CAH) Stock Research - Grey Stern Research

Cardinal Health, Inc. (CAH) Stock Analysis

$122.84 (-1.92%)

CAH Financial Performance


Use the table below to view Cardinal Health, Inc.'s financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q1 - 2025

Metric Value Ranking among Peers
Price $122.84 -
52 Week Low $93.17 -
52 Week High $126.23 -
Market Cap $29.7 Billion 3/8
Gross Margin 4% 6/8
Profit Margin 1% 3/8
EBITDA margin 1% 4/8
Q1 - 2025 Revenue $52.3 Billion 3/8
Q1 - 2025 Earnings $416.0 Million 2/8
Q1 - 2025 Free Cash Flow -$1.7 Million 7/8
Trailing 4 Quarters Revenue $224.5 Billion 3/8
Trailing 4 Quarters Earnings $1.3 Billion 3/8
Quarterly Earnings Growth 8220% 1/8
Annual Earnings Growth 775% 1/8
Quarterly Revenue Growth -5% 8/8
Annual Revenue Growth 4% 5/8
Cash On Hand $2.9 Billion 2/8
Short Term Debt $940.0 Million 1/8
Long Term Debt $4.2 Billion 2/8

Cardinal Health, Inc. Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare Cardinal Health, Inc.'s metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE 23.54 4/8
PS 0.13 6/8
PB 0.00 8/8
PC 10.37 6/8
Liabilities to Equity 0.00 8/8
ROA 0.03 4/8
ROE -0.39 7/8
Current Ratio 0.93 8/8
Quick Ratio 0.06 4/8
Long Term Debt to Equity -1.29 8/8
Debt to Equity -1.58 8/8
Burn Rate -238.12 8/8
Cash to Cap 0.10 2/8
CCR -4.18 6/8
EV to EBITDA 42.42 7/8
EV to Revenue 0.14 7/8

Company Details

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. It has a collaboration agreement with Journey Biosciences, Inc. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.

CEO: Mr. Michael Kaufmann

Website: https://www.cardinalhealth.com

Address: 7000 Cardinal Pl Dublin Ohio, OHIO

Exchange: New York Stock Exchange

Industry: Medical Distribution

Cardinal Health, Inc. Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to Cardinal Health, Inc.. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
Patterson Companies, Inc. PDCO $2.0 Billion
Henry Schein, Inc. HSIC $9.0 Billion
McKesson Corporation MCK $77.1 Billion
AmerisourceBergen Corporation ABC $36.1 Billion
Owens & Minor, Inc. OMI $1.1 Billion
EDAP TMS S.A. EDAP $86.1 Million
Zynex, Inc. ZYXI $252.9 Million
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
CAH Income Statements
Quarter Year Revenue Earnings
Q1 2025 $ 52.3 Billion $416.0 Million
Q4 2024 $ 59.9 Billion $236.0 Million
Q3 2024 $ 54.9 Billion $258.0 Million
Q2 2024 $ 57.4 Billion $353.0 Million
Q1 2024 $ 54.8 Billion $5.0 Million
Q4 2023 $ 53.5 Billion -$64.0 Million
Q3 2023 $ 50.5 Billion $345.0 Million
Q2 2023 $ 51.5 Billion -$130.0 Million

View All

CAH Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q1 2025 $2.9 Billion $43.1 Billion $5.2 Billion -$3.3 Billion
Q4 2024 $5.1 Billion $45.1 Billion $5.6 Billion -$3.2 Billion
Q3 2024 $3.7 Billion $45.9 Billion $5.9 Billion -$3.3 Billion
Q2 2024 $4.6 Billion $46.6 Billion $4.7 Billion -$3.4 Billion
Q1 2024 $3.9 Billion $43.7 Billion $4.7 Billion -$3.5 Billion
Q4 2023 $4.0 Billion $43.4 Billion $4.7 Billion -$2.9 Billion
Q3 2023 $4.0 Billion $43.4 Billion $4.7 Billion -$2.2 Billion
Q2 2023 $3.7 Billion $44.5 Billion $5.3 Billion -$2.2 Billion

View All

CAH Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q1 2025 -$1.7 Billion -$90.0 Million -$2.3 Billion
Q4 2024 $1.9 Billion -$193.0 Million $1.4 Billion
Q3 2024 -$161.0 Million -$112.0 Million -$873.0 Million
Q2 2024 $1.1 Billion -$114.0 Million $737.0 Million
Q1 2024 $453.0 Million -$92.0 Million -$189.0 Million
Q4 2023 $641.0 Million -$217.0 Million $53.0 Million
Q3 2023 $1.3 Billion -$109.0 Million $336.0 Million
Q2 2023 $512.0 Million -$85.0 Million $162.0 Million

View All

Cookies

We use cookies to offer a better browsing experience. Cookies enhance site navigation, analyze site usage, and assist in our marketing efforts. By clicking Accept. you agree to the storing of cookies on your device. To refuse all non-required cookies, click on Decline.

Accept View Terms & Conditions